Siemens Healthineers paper was subjected to an in-depth examination by amber Research-Analyst Lisa Bedell Clive.
The US analysis house Bernstein Research left the classification for Siemens Healthineers on “Outperform” with a price target of 59 euros. The “Best of Bernstein Pick” for the third quarter is the stock of the medical technology company, wrote Lisa Bedell Clive in a study available on Wednesday. She referred to the strong success story and, due to a possible further partial sale by the parent company Siemens, takes into account “more than sufficient” in the current course due to a possible further partial sale.
Between the course and quarter: So it is about the Siemens Healthineers share on the day of the detailed examination
The Siemens Healthineers share was in the Xetra meeting at 4:06 pm 1.2 percent in plus EUR 47.47. So the paper still has a development option of 24.29 percent compared to the defined price target. The trading volume last was 256,976 Siemens Healthineers shares. The paper has lost 5.7 percent since the beginning of 2025. Siemens Healthineers should present the key figures for Q3 2025 on July 30, 2025.
New York (dpa-AfX analyzer) / Redaktion finanzen.net
Publication of the original study: 08.07.2025 / 21:47 / UTC
First disclosure of the original study: 09.07.2025 / 05:00 / UTC
Note: Information on the obligation to disclose the disclosure for conflicts of interest within the meaning of Section 85 (1) WPHG, Art. 20 VO (EU) 596/2014 For the Analysten House mentioned can be found at http://web.dpa-afx.de/offengegungs-
Selected leverage products on Siemens Healthineers
With knock-outs, speculative investors can participate disproportionately in price movements. Simply choose the desired lever and we will show you suitable open-end products on Siemens Healthineers
The lever must be between 2 and 20
Advertising